Literature DB >> 25092355

Prevalence of vulvodynia and risk factors for the condition in Portugal.

Pedro Vieira-Baptista1, Joana Lima-Silva2, João Cavaco-Gomes2, Jorge Beires2.   

Abstract

OBJECTIVE: To investigate the prevalence of vulvodynia in Portugal and factors associated with this condition.
METHODS: In a cross-sectional study, an online survey was distributed by email and posted on a website and social networks. Women aged at least 18 years who were living in Portugal were eligible to complete the survey between June 1 and November 30, 2013. Participants had to have had symptoms for at least 6 months to be deemed to have vulvodynia.
RESULTS: Overall, 1229 questionnaires were included in analyses. A total of 80 (6.5%) women had vulvodynia at the time of the survey, and 117 (9.5%) had had it previously; lifetime prevalence was 16.0%. Pregnancy and type of delivery were not associated with vulvodynia. Women who had ever taken oral contraceptives were significantly more likely to have ever had vulvodynia (P<0.010). Candidiasis, genital herpes, urinary tract infections, depression, and premenstrual syndrome were associated with ever having had vulvodynia (P<0.01). Pain syndromes were associated with ever having had vulvodynia, especially fibromyalgia and bladder pain syndrome (P<0.001). Scoliosis and hysterectomy were also significantly associated (P<0.01).
CONCLUSION: The prevalence of vulvodynia in Portugal is similar to that elsewhere. Three main groups of factors might lead to vulvodynia: local inflammatory factors, general pain susceptibility, and pelvic nerve interference.
Copyright © 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Europe; Portugal; Vulvar disease; Vulvar pain; Vulvodynia

Mesh:

Year:  2014        PMID: 25092355     DOI: 10.1016/j.ijgo.2014.05.020

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  7 in total

Review 1.  Vulvodynia.

Authors:  Sophie Bergeron; Barbara D Reed; Ursula Wesselmann; Nina Bohm-Starke
Journal:  Nat Rev Dis Primers       Date:  2020-04-30       Impact factor: 52.329

2.  Vulvodynia: A disease commonly hidden in plain sight.

Authors:  Pedro Vieira-Baptista; Joana Lima-Silva; Faustino R Pérez-López; Mario Preti; Jacob Bornstein
Journal:  Case Rep Womens Health       Date:  2018-09-12

3.  Internet-based treatment for vulvodynia (EMBLA) - Study protocol for a randomised controlled study.

Authors:  Andrea Hess Hess Engström; Merit Kullinger; Izabella Jawad; Susanne Hesselman; Monica Buhrman; Ulf Högberg; Alkistis Skalkidou
Journal:  Internet Interv       Date:  2021-04-20

4.  High rate of dyspareunia and probable vulvodynia in Ehlers-Danlos syndromes and hypermobility spectrum disorders: An online survey.

Authors:  Jennifer E Glayzer; Barbara L McFarlin; Marco Castori; Marie L Suarez; Monya C Meinel; William H Kobak; Alana D Steffen; Judith M Schlaeger
Journal:  Am J Med Genet C Semin Med Genet       Date:  2021-11-07       Impact factor: 3.359

5.  Potential for Selection Bias in Studies of the Association of Hormonal Contraception and Chronic Vulvar Pain.

Authors:  Julia C Bond; Jacob J Kachura; Matthew P Fox; Jennifer Weuve; Bernard L Harlow
Journal:  J Womens Health (Larchmt)       Date:  2021-06-29       Impact factor: 2.681

Review 6.  Provoked vestibulodynia: current perspectives.

Authors:  Helen Henzell; Karen Berzins; Jennifer P Langford
Journal:  Int J Womens Health       Date:  2017-09-11

7.  Feasibility and acceptability of somatocognitive therapy in the management of women with provoked localized vestibulodynia-ProLoVe feasibility study.

Authors:  Mette Bøymo Kaarbø; Kristine Grimen Danielsen; Gro Killi Haugstad; Anne Lise Ording Helgesen; Slawomir Wojniusz
Journal:  Pilot Feasibility Stud       Date:  2022-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.